Design Therapeutics(DSGN.US)

Last Updated 19:00:00 ET
longbridge loading

Pre-market hot trades in US stocks: Clinical data causes fluctuations, Design Therapeutics pre-market down 5.79%, where is market sentiment heading?

Price Alert·
US
DSGN
-2.15%
Price Alert·
US
DSGN
-2.15%

U.S. stock night trading volatility: Design Therapeutics fell 3.46% in after-hours trading, as positive news failed to counteract market sentiment fluctuations

Price Alert·
US
DSGN
-2.15%
Price Alert·
US
DSGN
-2.15%

Top 10 US Stock Losers (5.18)

Top Gainers&Losers·
US
DSGN
-2.15%
US
RXT
+0.52%
US
FCEL
-7.38%
Top Gainers&Losers·
US
DSGN
-2.15%
US
RXT
+0.52%
US
FCEL
-7.38%

Design Therapeutics, Inc. Stock 12‑Month Price Target Raised to $20, Implies 39% Upside

TradingView·
US
DSGN
-2.15%
US
PBE
-0.24%
US
FBT
-0.28%
TradingView·
US
DSGN
-2.15%
US
PBE
-0.24%
US
FBT
-0.28%

This Biotech Leader Ran Up As Much As 18% — And Then Lost It All

Unusual Whales·
US
DSGN
-2.15%
US
XBI
-1.75%
US
LABU
-5.39%
Unusual Whales·
US
DSGN
-2.15%
US
XBI
-1.75%
US
LABU
-5.39%
© 2026 Longbridge｜Disclaimer